Mid-term Ministry, COVID-19 vaccine syringe smart factory site inspection
Input: 2021.02.19 10:24
[헬로티]
Minister of Small and Medium Venture Business Kwon Chil-seung said that Poonglim Pharmatech’s vaccine syringe smart factory was inspected and employees’ hard work was encouraged.
The Ministry of SMEs and Startups (hereinafter referred to as the Ministry of SMEs) visited Poonglim Pharmatech’s LDS vaccine production site, which was approved for use by the US Food and Drug Administration (FDA), and inspected the production site of the vaccine syringe smart factory.
Poonglim Pharmatech has established a mass-production system capable of producing more than 10 million units per month of “least residual type (LDS) vaccine syringes equipped with safety protection devices” in just one month through a coexistence type smart factory with small and medium-sized enterprises and Samsung Electronics. In cooperation with Samsung Bioepis/Samsung Biologics, it applied for approval of the use of the syringe to the US Food and Drug Administration (FDA) on January 18th.
According to the approval of the US Food and Drug Administration (FDA), Poonglim Pharmatech announced that it will proceed with export consultations with US pharmaceutical companies.
In addition, Poonglim Pharmatech said that there are inquiries about supplying minimum residual type (LDS) vaccine syringes from pharmaceutical companies, including 180 million in the US and about 80 million in Japan.
The 3rd factory (new factory) under construction has additionally built a smart factory production system of more than 10 million LDS vaccine syringes per month (February), the world’s largest minimum residual type (LDS) of more than 20 million units per month. ) It plans to have a vaccine syringe supply system.
In addition, Minister Kwon held a meeting with the vaccine syringe industry following the inspection on the production site to listen to industry opinions such as Doowon Meditech and Shin-A Corporation regarding the production and export of LDS vaccine syringes.
At this meeting, the industry announced that it has a sufficient vaccine syringe supply system to prevent any disruption in domestic vaccination such as expansion of production facilities in preparation for a surge in supply since last year.
Doowon Meditech has been selected as a supplier of syringes for corona 19 vaccination by the Korea Centers for Disease Control and Prevention and will supply a total of 27.5 million units by the end of July. It also revealed that it has the ability to deliver more than three times the existing production through preemptive facility investment.
Shin-A Corporation is also planning to supply a total of 12.5 million units to the Korea Centers for Disease Control and Prevention by the first half of the year, and based on the experience of exporting approximately 500 million LDS syringes to the United States from 1995 until now, we have recently discussed exports with various countries including Europe and the Middle East. Is doing.
In particular, Poonglim Pharmatech announced that it will first donate 127,000 LDS vaccine syringes to 60,000 people vaccinated by Pfizer in the United States, and it is in a position to consult with the Korea Centers for Disease Control and Prevention along with overseas exports.
Minister Kwon said, “Based on Poonglim Pharmatech’s achievements in public-private win-win cooperation, we are promoting the supply of smart factories to vaccine injection companies other than Poonglim. We plan to promote the supply of smart factories in earnest.”
In addition, Minister Kwon said, “To ensure that such manufacturing innovation results can lead to export, we provide customized support throughout the entire export cycle, such as pre-consulting, certification and standard acquisition, and overseas marketing package support, and online globalization support such as online/offline connection (O2O) exhibitions. We plan to do it in parallel.”
In addition, “Poonglim’s vaccine syringe is the crystal of K-quarantine, created by the will and efforts of Korean SMEs, Samsung’s technology, and the government’s support,” he said. “We will try to spread the power of win-win cooperation.” .